New Pharma Funded Company NewsGuard Claims To Fight Against Fake News

New Pharma Funded Company NewsGuard Claims To Fight Against Fake News


A new company called NewsGuard says that they
can protect you from fake news, but the corporations
funding that group have real different motives.
This is an amazing story.
Lay it out for us.
I mean, this is such an extraordinary story.
I go, really?
This is happening in 2020.
Go ahead.
Well you actually, it starts with a very well
respected guy, Steve Brill, started court
TV.
Was a, was a great lawyer.
Ah, I wouldn’t go that far, but anyway.
Decides he wants to help fight fake news,
you know, very noble cause.
And so he says, well, in order to fight fake
news and create NewsGuard, I’m going to need
some money.
So he goes to this group called Publicis Groupe,
and it turns out that Publicis Groupe is funded
in part, a lot of their money, billions of
dollars is coming from healthcare companies,
from pharmaceutical companies.
The very companies that control the corporate
media have now paid in a couple million dollars
to help Mr Brill found this NewsGuard app
plugin, I guess for your, for your browser,
that’s now going to tell you when you go to
a website, oh, NewsGuard says this is fake.
Or NewsGuard says this is a green light, we
approve of what’s on this site.
Okay.
Let me comment two things about what you just
said.
Brill has always been a corporate lawyer.
He’s never done anything for consumers.
I mean, really he, whatever he wants to sell,
the guy is center of corporate America.
These are the people that Mr Brill and this
company went to, to try to get funding for
this.
Follow me.
Eli Lilly, Abbott, Roche, AstraZeneca, GlaxoSmithKline,
I mean, it’s, it’s a lineup of the worst offenders
of defective pharmaceuticals in the country.
Now, what is going to happen is when we do
a story like this, if you were to go to NewsGuard,
right, NewsGuard would tell you don’t go to
that site because they’re telling stories
that are fake news.
This is not fake news.
This is absolutely, fortunately, you had a
great writer that, that handle, that’s handling
this, this story who’s done all the investigation.
And he says, look, if you believe this, if
you believe the ratings that NewsGuard gives,
then you’re kidding yourselves into under,
you’re kidding yourselves about the truth
of the matter.
Well, well NewsGuard has already rated RT,
they say RT is fake news.
They say Daily Kos is fake news, according
to NewsGuard.
Really?
Breitbart, Daily Caller.
So it’s, it’s left, It’s right.
It’s everything that doesn’t fit into NewsGuard’s
narrative.
Which is pro corporation.
Right, of what news is.
If it’s not New York Times or Washington Post,
it’s not real.
Right.
But right now, investigative journalism is
not taking place at these traditional media
outlets.
It’s taking place with these independent outlets
that NewsGuard says, sorry, you’re fake.
Yeah.
If it’s not corporate, if it’s not pro pharmaceutical,
if it’s not pro, pro chemical, if it’s not
pro Wall Street, then it’s fake news.
Now what about the idiot who says, yeah, I’m
going to use this?
What about the idiot who says, I’m gonna use
Snopes?
Snopes is the same thing.
You’ve got some cat with a clear agenda that’s
saying, don’t go to this site because they’re
not telling the truth.
No, it’s don’t go to this site because they’re
saying things that are scaring the bejesus
out of us because the corporate backing on
this is deplorable.
So if you want to believe Pfizer or you want
to believe an independent source, they’re
saying, oh, you can believe Pfizer, Dow Chemical,
DuPont, Boeing, McDonnell Douglas.
You can believe them, don’t, but don’t believe
that site.
Well, see with, with Snopes.
I disagree with this author’s assessment of
them.
Okay.
I, I think that that’s, that’s inaccurate
what he said about them.
But with the NewsGuard, this is absolutely,
the funding has been traced.
You see it in the documents.
This group got money from a group that gets
their money from these healthcare industries.
Yeah, which hasn’t been proven by Snopes.
But who wants a organization like Snopes making
that decision for you, right?

25 thoughts on “New Pharma Funded Company NewsGuard Claims To Fight Against Fake News”

  1. Big Pharma is the biggest funder of the MSM, bigger than war and oil. The only way we can get truth about medical issues is via independent news, what they call fake news. But the real fake news is the pro-big-pharma news.

  2. There is no fake news. We all get news and we all get BS… It is the weak minded who, in this age of information, don't have the mental capacity to research and inform themselves to truth and fact. They are ignorant by choice and cry, "fake news," exposing their inability to learn.

  3. Just like my old job's newsletter. It was nothing more than a thinly veiled propaganda. With statements on how Bush was a great president & that there is no recession.

  4. If they were really against fake news then they will have to admit that not only do their toxic chemicals not work but are the number one cause of unnatural death in the US; they will have to tell the truth about vaccinations and how they are totally ineffective.

  5. SNOPES lies a lot and has been caught. Also OpEdNews has a long list of about 40 to 50 subjects that are not allowed published as they infringe on big business.

  6. Well.. we all asked for it right? When we claim anti-vaccers, homeopathic plant medicinal treatments, baby powder causing cancer, both sides of climate change science, and a host of conspiracy theories that turn out to be true, are fake news.. That gives an inch for big pharma, news media, and other industries to create such shit to stifle free exchange.

  7. Big pharma knew about the properties of Fenbendazole, Mebendazole Fish Bendazole in 2008. You didn't hear a word about it. https://youtu.be/-WxiPf-NEDk     How Joe Tippens beat terminal small cell lung cancer with a $7 dog deworming medicine. 

    Dr. Andrew Jones DVM Explains Panacur’s effects: https://youtu.be/AvvDrQqZrG0 

    Kerri Parker Ex Miss U.K. Surviving a brain tumor:  https://youtu.be/MFDll5hp-Wk 

    Kerri Parker lays out her protocol:  https://youtu.be/nZfusCtQ-SM 

    Kerri Parker Panacur and Fenbendazole is curing my brain cancer: https://youtu.be/sBVtsvkcTII 

    Panacur’s effects, increasing P53 activity, inhibiting cancer cell tubules, blocking cancer cells metabolization of sugar. These properties are explained in the 2008 research paper below.

    READING JOE'S BLOG IS A MUST. www.MyCancerStory.Rocks 

    Protocol: 

    800 iu high quality vitamin E to aid with absorption daily

    25 Mg CBD daily

    600 Mg Turmeric/Curcumin daily 

    222 Mg Panacur C (Fenbendazole) 3 days on, 4 days off

    It should be noted that for hormone driven cancers Fish Bendazole is said to be more applicable.

    https://www.lewrockwell.com/2019/05/bill-sardi/a-cancer-cure-has-gotten-out-of-control-and-has-spread-beyond-the-confines-of-modern-medicine/ 

    While Wall Street awaits the entry of over 1,813 new cancer drugs into human clinical trials representing billions of dollars of investment capital, the announcement of a bona fide cure for cancer comes from an outsider – patient Joe Tippens.

    An astounding report of Mr. Tippens’ cancer cure is circulating the internet now.  First diagnosed with small cell lung cancer in 2016 and with tumors popping up on scans in virtually every organ in his body, in desperation Joe Tippens began using a dog de-worming agent at the suggestion of a veterinarian.

    He was told this cancer cure “was batting 1,000 in killing different cancers.”  He heard one of the scientists involved in the research was cured. He had no time to dither.  He was weeks away from dying.

    Treatment began in the third week of January 2017.  Three months later at MD Anderson Cancer Hospital in Houston, Tippens anxiously awaited the report of his oncologist who had no idea Tippens started taking the dog deworming medication.

    The doctor is reported to have walked up to Mr. Tippens and said: “I am going to have to ask you to leave this hospital, because we only treat patients with cancer here at MD Anderson.”

    Within just 3 months his cancer vanished.  His insurance company spent $1.2 million before Tippens switched to a $5 a week medicine that saved his life.  Daily vitamins and CBD oil were also an essential part of his curative regimen. Here’s the video report.

    Unexpected antitumorigenic effect of fenbendazole when combined with supplementary vitamins.

    Gao P, et al. J Am Assoc Lab Anim Sci. 2008.

    Show full citation

    Abstract 

    Diet containing the anthelminthic fenbendazole is used often to treat rodent pinworm infections because it is easy to use and has few reported adverse effects on research. However, during fenbendazole treatment at our institution, an established human lymphoma xenograft model in C.B-17/Icr-prkdcscid/Crl (SCID) mice failed to grow. Further investigation revealed that the fenbendazole had been incorporated into a sterilizable diet supplemented with additional vitamins to compensate for loss during autoclaving, but the diet had not been autoclaved. To assess the role of fenbendazole and supplementary vitamins on tumor suppression, 20 vendor-supplied 4-wk-old SCID mice were assigned to 4 treatment groups: standard diet, diet plus fenbendazole, diet plus vitamins, and diet plus both vitamins and fenbendazole. 

    Diet treatment was initiated 2 wk before subcutaneous flank implantation with 3 x 107 lymphoma cells. Tumor size was measured by caliper at 4-d intervals until the largest tumors reached a calculated volume of 1500 mm3. Neither diet supplemented with vitamins alone nor fenbendazole alone caused altered tumor growth as compared with that of controls. However, the group supplemented with both vitamins and fenbendazole exhibited significant inhibition of tumor growth. The mechanism for this synergy is unknown and deserves further investigation. Fenbendazole should be used with caution during tumor studies because it may interact with other treatments and confound research results.

    PMID 19049251 [Indexed for MEDLINE] PMCID PMC2687140

    James Templeton Foundation Interviews Joe Tippens https://youtu.be/fCOODjrJhRQ 

    https://www.thehindubusinessline.com/news/science/veterinary-drug-may-be-repurposed-for-human-cancers-study/article24793200.ece/amp/ 

    News Science 

    Veterinary drug may be repurposed for human cancers: study

    Yogesh Sharma Updated on August 27, 2018

    Indian scientists have found that fenbendazole, a broad-spectrum anti-parasitic drug used in veterinary sector, could be useful against cancers as well.

    Researchers at the National Centre for Human Genome Studies and Research (NCHGSR), Panjab university, have reported that fenbendazole has a good potential for development as an effective anti-cancer agent. It is currently used as used to treat infections caused by parasitic worms in animals like horses. The study results have been published in journal Scientific Reports.

    To check the effectiveness of fenbendazole, researchers first treated human ‘non-small cell lung cancer cells’ (type of lung cancer cells) with fenbendazolem and analysed cancer cells with immunofluorescence technique. They found that the drug causes partial alteration of microtubule network around the cell nucleus. Tumour cell lines also showed enhanced cell death-inducing activity in the presence of wild type (WT) p53 tumour suppressor genes.

    Researchers tested fenbendazole in mice, feeding them the drug orally every second day for 12 days. After the end of 12 th day, tumours were excised, measured and weighed.

    Researchers found reduction in tumour size and weight. Results suggested that fenbendazole inhibits tumour cell growth in vivo by inducing apoptosis of tumour cells.

    Cancer cells are known to show increased glucose uptake for their energy requirements. So, researchers tested the effect of fenbendazole on glucose uptake in human cancer cells. Two different type of cancer cells, H460 and A549 cells, were treated with fenbendazole.

    Researchers found inhibition in glucose uptake in both the cell lines According to researchers, fenbendazole may also be advantageous in evading drug resistance commonly encountered in cancer therapy. Since the process of tumorigenesis Reduced tumour size in mice fed with fenbendazole for 12 days involves a number of genes and proteins altering various cell signaling pathways, single-target drugs often show limited efficacy and may lead to drug resistance. Drugs having multiple cellular targets, therefore, are expected to have improved efficacy besides the ability to circumvent the likelihood of developing resistance.

    “Our findings show that fenbendazole acts through moderate microtubule disruption, p53 stabilization and interference with glucose metabolism leading to preferential elimination of cancer cells both in vitro and in vivo”, explained Dr. Tapas Mukhopadhyay, former director, NCHGSR, who led the study, while speaking to India Science Wire.

    The use of microtubule targeting agents (MTAs) for treatment of multiple tumour types is very common but their effectiveness is often hampered due to drug resistance.

    “Usually, development of new drugs requires a considerable amount of time, money and effort. Developing a promising molecule into an approved drug often takes several years. It is therefore, crucial to employ strategies to overcome these impediments. Repurposing of veterinary drugs showing promising results for human use can result in considerable time and cost reduction required to develop new drugs,” said Dr. Mukhopadhyay.

    According to the researchers fenbendazole is known for a high safety margin and most species tolerate it very well. It has very low degree of toxicity and high degree of safety in experimental animals. Hence it can be a good candidate for anticancer therapy.

    Alternatively, it can also be used as an adjuvant therapy.

    “FDA as well as other published pre-clinical data on the toxicological studies performed on animals shows that fenbendazole administered in different species at dosages several times the approved dosage does not cause any adverse effects in animals. Further, our previous study also showed minimal toxicity of fenbendazole in normal human cells. Considering this information, FZ can be an ideal candidate for development as an anti-cancer agent”, added Dr. Mukhopadhyay.

    Besides Dr Mukhopadhyay and Dr. Ashok Kumar from Panjab University, the research team included Dr. Nilambra Dogra from Postgraduate Institute of Medical Education and Research, Chandigarh.

  8. The lack of awareness of this guy. I already don't like him for his anti-vaping propaganda but now he is saying, to all of us, to not goto a website like snopes because they have an agenda… like, your literally doing the same thing that snopes does, except your doing it because you need to discredit other websites to try and get the dummies to believe you. Your doing what your complaining about other people doing. Fucking hypocrite.

  9. I'm going to go out on a limb and say 99.9% of the pharmaceutical ads on television are for products that are totally unnecessary

Leave a Reply

Your email address will not be published. Required fields are marked *

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,